Cerenome (CNSY) EBITDA Margin (2011 - 2026)
Cerenome's EBITDA Margin was -2170.32% in Q2 2026, down 2065.21 percentage points from -105.11% a year earlier and down 1487.15 percentage points from the prior quarter.
Powered by 
Analysis
Cerenome (CNSY) EBITDA Margin (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Cerenome's EBITDA Margin was -617.30% through Jun 30, 2026, down 391.55 percentage points year-over-year; for FY2025, it came in at -284.92%, down 47.58 percentage points from FY2024.
- EBITDA Margin shows a three-year change of +8238.74 percentage points (FY2022 to FY2025).
- In earlier years, EBITDA Margin was -237.35% in FY2024 (+21.01 pp), -258.36% in FY2023 (+8265.31 pp) and -8523.66% in FY2022.
- The Q2 2026 figure marks the lowest quarterly EBITDA Margin since Q4 2022.
- Compared with a year earlier, EBITDA Margin has declined for four straight quarters, with an average year-over-year change of -345.30 percentage points over the last eight quarters.
- The best year-over-year quarter for EBITDA Margin over five years was Q3 2023 (a gain of 6691.37 percentage points); the worst was Q2 2026 (a drop of 2065.21 percentage points).
- Per Business Quant data, CNSY's EBITDA Margin in the three quarters before Q2 2026 was -683.17% (Q1 2026), -409.44% (Q4 2025) and -315.32% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 39.10% |
| 10 | Cerenome | 13.60 Mn | -33.58 Mn | - | -2,170.32% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,170.32% |
| Mar 31, 2026 | -683.17% |
| Dec 31, 2025 | -409.44% |
| Sep 30, 2025 | -315.32% |
| Jun 30, 2025 | -105.11% |
| Mar 31, 2025 | -320.11% |
| Dec 31, 2024 | -251.56% |
| Sep 30, 2024 | -247.25% |
| Jun 30, 2024 | -275.76% |
| Mar 31, 2024 | -187.48% |
| Dec 31, 2023 | -282.33% |
| Sep 30, 2023 | -70.27% |
| Jun 30, 2023 | -70.00% |
| Mar 31, 2023 | -901.98% |
| Dec 31, 2022 | -3,584.77% |
| Sep 30, 2022 | -6,761.64% |
| Mar 31, 2019 | -245.09% |
| Dec 31, 2018 | -96.41% |
| Sep 30, 2018 | -202.45% |
| Jun 30, 2018 | -207.27% |
API Access
Cerenome EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CNSY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "CNSY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CNSY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();